Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Transmission probabilities and durations of immunity for three pathogenic group B Streptococcus serotypes.

Percha B, Newman ME, Foxman B.

Infect Genet Evol. 2011 Aug;11(6):1407-12. doi: 10.1016/j.meegid.2011.05.005. Epub 2011 May 14.

PMID:
21605704
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Bronze MS, Dale JB.

Am J Med Sci. 2010 Sep;340(3):218-25. doi: 10.1097/MAJ.0b013e3181e939ab. Review.

PMID:
20697258
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Streptococcus adherence and colonization.

Nobbs AH, Lamont RJ, Jenkinson HF.

Microbiol Mol Biol Rev. 2009 Sep;73(3):407-50, Table of Contents. doi: 10.1128/MMBR.00014-09. Review.

PMID:
19721085
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Yang HH, Mascuch SJ, Madoff LC, Paoletti LC.

Clin Vaccine Immunol. 2008 Jul;15(7):1035-41. doi: 10.1128/CVI.00030-08. Epub 2008 May 7.

PMID:
18463225
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.

Yang HH, Madoff LC, Guttormsen HK, Liu YD, Paoletti LC.

Infect Immun. 2007 Jul;75(7):3455-61. Epub 2007 Apr 30.

PMID:
17470542
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Group B Streptococcus: global incidence and vaccine development.

Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, Rappuoli R.

Nat Rev Microbiol. 2006 Dec;4(12):932-42. Epub 2006 Nov 6. Review.

PMID:
17088932
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity.

Michon F, Uitz C, Sarkar A, D'Ambra AJ, Laude-Sharp M, Moore S, Fusco PC.

Clin Vaccine Immunol. 2006 Aug;13(8):936-43.

PMID:
16893995
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Identification of a universal Group B streptococcus vaccine by multiple genome screen.

Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D'Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Nardi-Dei V, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G.

Science. 2005 Jul 1;309(5731):148-50. Erratum in: Science. 2013 Jan 11;339(6116):141. Nardi Dei, Vincenzo [corrected to Nardi-Dei, Vincenzo].

PMID:
15994562
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Lindahl G, Stålhammar-Carlemalm M, Areschoug T.

Clin Microbiol Rev. 2005 Jan;18(1):102-27. Review.

PMID:
15653821
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.

Larsson C, Holmgren J, Lindahl G, Bergquist C.

Infect Immun. 2004 Feb;72(2):1184-7.

PMID:
14742572
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.

Kong F, Gowan S, Martin D, James G, Gilbert GL.

J Clin Microbiol. 2002 Feb;40(2):620-6.

PMID:
11825981
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

bca, beta gene, and gene product divergency in reference and prototype strains of streptococcus agalactiae.

Maeland JA, Bevanger L, Iversen G, Lyng RV.

Clin Diagn Lab Immunol. 1999 Nov;6(6):986-8.

PMID:
10548599
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.

Navarre WW, Schneewind O.

Microbiol Mol Biol Rev. 1999 Mar;63(1):174-229. Review.

PMID:
10066836
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.

Gravekamp C, Rosner B, Madoff LC.

Infect Immun. 1998 Sep;66(9):4347-54.

PMID:
9712787
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Schuchat A.

Clin Microbiol Rev. 1998 Jul;11(3):497-513. Review.

PMID:
9665980
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy.

Wessels MR, Paoletti LC, Guttormsen HK, Michon F, D'Ambra AJ, Kasper DL.

Infect Immun. 1998 May;66(5):2186-92.

PMID:
9573106
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.

Li J, Kasper DL, Ausubel FM, Rosner B, Michel JL.

Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13251-6.

PMID:
9371832
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.

Lachenauer CS, Madoff LC.

Infect Immun. 1996 Oct;64(10):4255-60.

PMID:
8926097
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.

Gravekamp C, Horensky DS, Michel JL, Madoff LC.

Infect Immun. 1996 Sep;64(9):3576-83.

PMID:
8751902
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk